MASCC Antiemesis Tool (MAT)
About the MASCC Antiemesis Tool (MAT)
The MASCC Antiemesis Tool (MAT) is an easy-to-use and easy-to-evaluate tool designed to help cancer patients and professionals communicate accurately about the prevention and control of nausea and vomiting that may occur with chemotherapy. The MAT can also help treatment centers evaluate the effectiveness of their antiemetic strategies.
The tool was first created in 2004 and validated in 2007. It’s now available in multiple languages, and can also be downloaded as an app for iPhone/iPad or Android.
Download the MAT & Associated Resources
We recommend that you read the “Guide to Using the MAT” carefully before distributing or using it.
English:
The MASCC Antiemesis Tool: PDF | Word Doc
Guide to Using the MAT
MAT Patient Outcomes Scoresheet: PDF | Excel Spreadsheet
App:
MAT Apple QR code
MAT Android QR code
Translations
English
The MASCC Antiemesis Tool: PDF | Word Doc
MAT Patient Outcomes Scoresheet: PDF | Excel Spreadsheet
Albanian
Arabic
The MASCC Antiemesis Tool (MAT): PDF | Word Doc
MAT Patient Outcomes Scoresheet: PDF | Word Doc | Excel Spreadsheet
Translated by: Manal B. Al-Zaidan, BSc(Pharm), Doha-Qatar and Ahmed Eid, MD
Japanese
Korean
The MASCC Antiemesis Tool (MAT): PDF | Word Doc
MAT Patient Outcomes Scoresheet: PDF | Word Doc | Excel Spreadsheet
Translated by: Jiyeon Lee, RN, PhD, ACNP-BC, Eun-Hyun Lee, RN, PhD, & Heeyoung Oh, RN, PhD
Portuguese
Serbian
The MASCC Antiemesis Tool (MAT): PDF | Word Doc
MAT Patient Outcomes Scoresheet: PDF | Word Doc | Excel Spreadsheet
Translated by Snezana Bosnjak, MD, PhD
MAT Approval
Non-profit entities and health professionals (physicians, nurses, etc.) are encouraged to use the MAT and may do so free of charge. Commercial companies will require written approval from MASCC, and will incur a nominal fee prior to using this tool. Please contact the Executive Director at mascc.office@mascc.org for additional information regarding the approval procedure.
MASCC is grateful to the following individuals and organizations for their help in developing the MAT:
Development of the Tool:
- Sussanne Borjeson, RN, PhD
- Rebecca Clark-Snow, RN, BSN
- Rebecca Finley, PharmD, MS
- Richard J. Gralla, MD
- Mark G. Kris, MD
- Cynthia N. Rittenberg, RN, MN
Reviewers:
- Jørn Herrstedt, MD
- Patricia Hollen, RN, PhD
- Judi Johnson, RN, PhD
- Fausto Roila, MD
MASCC appreciates the unrestricted grant from Merck & Co., Inc., Whitehouse Station, NJ, USA, that was used to develop the MAT.
©MASCC, Multinational Association for Supportive Care in Cancer™ • All rights reserved worldwide.
